Evaluating cervical cancer screening for women over 65 years old
Cervical cancer screening after age 65 in the era of HPV testing: estimating benefits and harms of screening cessation and continuation
This study is looking into whether women over 65 should keep getting cervical cancer screenings, considering how long people are living and the possible risks of the tests, to help decide what's best for their health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10908553 on NIH RePORTER |
What this research studies
This research investigates whether women over the age of 65 should continue cervical cancer screening, given the increase in life expectancy and the potential risks associated with screening procedures. It aims to assess the benefits and harms of continuing or ceasing screening for this age group, particularly focusing on those who have been adequately screened. The study will analyze data to provide evidence-based recommendations for cervical cancer screening practices in older women.
Who could benefit from this research
Good fit: Ideal candidates for this research are women aged 65 and older who have undergone cervical cancer screening and are considering whether to continue or cease screening.
Not a fit: Patients who are younger than 65 or those who have not been adequately screened for cervical cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved guidelines for cervical cancer screening in older women, potentially reducing unnecessary procedures and associated risks.
How similar studies have performed: Previous research has highlighted the importance of cervical cancer screening, but this specific focus on women over 65 is relatively novel and addresses a significant gap in current guidelines.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Sawaya, George F — University of California, San Francisco
- Study coordinator: Sawaya, George F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.